MBRX: Moleculin Biotech Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Moleculin Biotech Inc (MBRX).
$5.10M Market Cap.
MBRX Market Cap. (MRY)
MBRX Shares Outstanding (MRY)
MBRX Assets (MRY)
Total Assets
$16.93M
Total Liabilities
$10.95M
Total Investments
$0
MBRX Income (MRY)
Revenue
$0
Net Income
-$21.76M
Operating Expense
$26.64M
MBRX Cash Flow (MRY)
CF Operations
-$23.86M
CF Investing
-$13.00K
CF Financing
$4.63M
MBRX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $16,925,000 (-55.71%) | $38,217,000 (-33.45%) | $57,422,000 (-31.71%) | $84,090,000 (189.66%) |
Assets Current | $5,194,000 (-80.23%) | $26,273,000 (-42.38%) | $45,596,000 (-37.11%) | $72,497,000 (321.54%) |
Assets Non-Current | $11,731,000 (-1.78%) | $11,944,000 (1.00%) | $11,826,000 (2.01%) | $11,593,000 (-2.03%) |
Goodwill & Intangible Assets | $11,148,000 (0.00%) | $11,148,000 (0.00%) | $11,148,000 (0.00%) | $11,148,000 (0.00%) |
Shareholders Equity | $5,979,000 (-77.07%) | $26,073,000 (-50.04%) | $52,191,000 (-33.93%) | $78,993,000 (344.78%) |
Property Plant & Equipment Net | $583,000 (-26.76%) | $796,000 (17.40%) | $678,000 (52.36%) | $445,000 (-35.04%) |
Cash & Equivalents | $4,278,000 (-81.83%) | $23,550,000 (-45.42%) | $43,145,000 (-39.15%) | $70,903,000 (367.30%) |
Accumulated Other Comprehensive Income | -$41,000 (-355.56%) | -$9,000 (-175.00%) | $12,000 (-70.73%) | $41,000 (-36.92%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,030,000 (-18.73%) | $2,498,000 (19.24%) | $2,095,000 (53.59%) | $1,364,000 (20.81%) |
Accumulated Retained Earnings (Deficit) | -$153,367,000 (-16.54%) | -$131,604,000 (-29.23%) | -$101,835,000 (-39.86%) | -$72,810,000 (-27.93%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $358,000 (-24.47%) | $474,000 (41.49%) | $335,000 (431.75%) | $63,000 (-60.38%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $358,000 (-24.47%) | $474,000 (41.49%) | $335,000 (431.75%) | $63,000 (-60.38%) |
Total Liabilities | $10,946,000 (-9.86%) | $12,144,000 (132.15%) | $5,231,000 (2.63%) | $5,097,000 (-54.78%) |
Liabilities Current | $5,359,000 (-21.36%) | $6,815,000 (41.42%) | $4,819,000 (33.05%) | $3,622,000 (24.04%) |
Liabilities Non-Current | $5,587,000 (4.84%) | $5,329,000 (1193.45%) | $412,000 (-72.07%) | $1,475,000 (-82.34%) |
MBRX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $8,786,000 (-12.29%) | $10,017,000 (-13.21%) | $11,542,000 (37.63%) | $8,386,000 (23.60%) |
Research & Development Expense | $17,729,000 (-9.02%) | $19,487,000 (2.74%) | $18,968,000 (31.56%) | $14,418,000 (13.02%) |
Operating Expenses | $26,641,000 (-10.09%) | $29,631,000 (-3.29%) | $30,640,000 (33.40%) | $22,968,000 (16.34%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$21,763,000 (26.89%) | -$29,769,000 (-2.56%) | -$29,025,000 (-82.62%) | -$15,894,000 (8.42%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$21,763,000 (26.89%) | -$29,769,000 (-2.56%) | -$29,025,000 (-82.62%) | -$15,894,000 (8.42%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$21,763,000 (26.89%) | -$29,769,000 (-2.56%) | -$29,025,000 (-82.62%) | -$15,894,000 (8.42%) |
Weighted Average Shares | $3,442,997 (74.28%) | $1,975,610 (-93.09%) | $28,604,397 (6.43%) | $26,875,927 (172.97%) |
Weighted Average Shares Diluted | $3,442,997 (74.28%) | $1,975,610 (-93.09%) | $28,604,397 (6.43%) | $26,875,927 (172.97%) |
Earning Before Interest & Taxes (EBIT) | -$21,763,000 (26.89%) | -$29,769,000 (-2.56%) | -$29,025,000 (-82.62%) | -$15,894,000 (8.42%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$26,641,000 (10.09%) | -$29,631,000 (3.29%) | -$30,640,000 (-33.40%) | -$22,968,000 (-16.34%) |
MBRX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$13,000 (89.52%) | -$124,000 (-85.07%) | -$67,000 (-252.63%) | -$19,000 (94.92%) |
Net Cash Flow from Financing | $4,635,000 (-0.34%) | $4,651,000 (20321.74%) | -$23,000 (-100.03%) | $74,724,000 (231.38%) |
Net Cash Flow from Operations | -$23,862,000 (0.99%) | -$24,101,000 (12.80%) | -$27,639,000 (-45.84%) | -$18,951,000 (-6.64%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$19,272,000 (1.65%) | -$19,595,000 (29.41%) | -$27,758,000 (-149.81%) | $55,730,000 (1155.75%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$13,000 (89.52%) | -$124,000 (-85.07%) | -$67,000 (-252.63%) | -$19,000 (94.92%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $4,661,000 (11.88%) | $4,166,000 (0%) | $0 (0%) | $74,747,000 (231.24%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$32,000 (-52.38%) | -$21,000 (27.59%) | -$29,000 (-20.83%) | -$24,000 (-170.59%) |
Share Based Compensation | $1,726,000 (-13.00%) | $1,984,000 (-12.79%) | $2,275,000 (-4.13%) | $2,373,000 (41.25%) |
Depreciation Amortization & Accretion | $126,000 (-0.79%) | $127,000 (-2.31%) | $130,000 (-20.73%) | $164,000 (-18.00%) |
MBRX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -165.00% (-103.96%) | -80.90% (-73.98%) | -46.50% (-143.46%) | -19.10% (82.62%) |
Return on Average Assets (ROAA) | -90.00% (-32.94%) | -67.70% (-60.43%) | -42.20% (-142.53%) | -17.40% (71.66%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 898.10% (-47.50%) | 1710.60% (19.61%) | 1430.20% (17.18%) | 1220.50% (-92.42%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.27 (68.50%) | -0.85 (18.67%) | -1.05 (66.70%) | -3.15 (-16.05%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.85 (-12.95%) | 0.98 (68.85%) | 0.58 (-13.67%) | 0.67 (-76.00%) |
Debt to Equity Ratio (D/E) | 1.83 (292.92%) | 0.47 (366.00%) | 0.1 (53.85%) | 0.07 (-89.76%) |
Earnings Per Share (EPS) | -6.32 (58.06%) | -15.07 (-1392.08%) | -1.01 (-71.19%) | -0.59 (66.48%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -6.93 (43.45%) | -12.26 (-1165.43%) | -0.97 (-37.25%) | -0.71 (61.69%) |
Book Value Per Share (BVPS) | 1.74 (-86.84%) | 13.2 (623.12%) | 1.82 (-37.90%) | 2.94 (62.92%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.68 (-87.75%) | 13.7 (746.85%) | 1.62 (-40.38%) | 2.71 (49.45%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 1 (0.00%) | 1 (150.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.18 (454.90%) | -0.05 (-107.49%) | 0.68 (-51.18%) | 1.4 (164.35%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.97 (-74.86%) | 3.85 (-59.26%) | 9.46 (-52.73%) | 20.02 (239.83%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$23,875,000 (1.44%) | -$24,225,000 (12.56%) | -$27,706,000 (-46.05%) | -$18,970,000 (-4.55%) |
Enterprise Value (EV) | -$3,911,778 (-359.70%) | $1,506,284 (107.65%) | -$19,681,503 (10.33%) | -$21,949,616 (-159.03%) |
Earnings Before Tax (EBT) | -$21,763,000 (26.89%) | -$29,769,000 (-2.56%) | -$29,025,000 (-82.62%) | -$15,894,000 (8.42%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$21,637,000 (27.01%) | -$29,642,000 (-2.59%) | -$28,895,000 (-83.69%) | -$15,730,000 (8.31%) |
Invested Capital | -$3,502,000 (-24.10%) | -$2,822,000 (-108.27%) | -$1,355,000 (10.86%) | -$1,520,000 (-2880.39%) |
Working Capital | -$165,000 (-100.85%) | $19,458,000 (-52.28%) | $40,777,000 (-40.80%) | $68,875,000 (382.39%) |
Tangible Asset Value | $5,777,000 (-78.66%) | $27,069,000 (-41.50%) | $46,274,000 (-36.56%) | $72,942,000 (307.88%) |
Market Capitalization | $5,103,222 (-80.06%) | $25,589,284 (-15.67%) | $30,345,497 (-42.91%) | $53,153,384 (6.75%) |
Average Equity | $13,187,500 (-64.16%) | $36,790,750 (-41.05%) | $62,408,000 (-25.14%) | $83,367,000 (428.07%) |
Average Assets | $24,184,750 (-45.01%) | $43,979,250 (-36.00%) | $68,712,500 (-24.93%) | $91,527,500 (223.91%) |
Invested Capital Average | -$2,423,250 (-39.25%) | -$1,740,250 (14.25%) | -$2,029,500 (-55.85%) | -$1,302,250 (-1108.58%) |
Shares | 3,001,895 (51.05%) | 1,987,363 (-93.06%) | 28,627,827 (0.18%) | 28,577,088 (174.50%) |
